International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced fourth quarter and year-end financial results for the period ended December 31, 2014.
http://ift.tt/19wWkPc
http://ift.tt/19wWkPc
No comments:
Post a Comment